Both in Pharmaceuticals
Tyra Biosciences vs Rapport Therapeutics
Over the past year TYRA returned +38.1% and RAPP returned −3.7%; their daily moves had a correlation of 0.35.
TYRA +38.1% RAPP −3.7%Growth of $1, one year, split-adjusted
| Metric | TYRA | RAPP |
|---|---|---|
| Price | $21.31 | $25.93 |
| Market cap | $1.46B | $1.46B |
| Today | −0.30% | +1.93% |
| 1 month | +5.3% | −16.8% |
| 6 months | −37.0% | −30.0% |
| Year to date | −19.0% | −14.5% |
| 1 year | +38.1% | −3.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 73.0× |
| Net cash | $353.9M | $436.1M |
| Dividend yield | — | — |
| Volatility (60d) | 74.2% | 79.1% |
| Short % of float | 26.5% | 10.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).